Delta Sleep-Inducing Peptide: The 30-Year Mystery That Still Has No Answer

Despite being discovered in 1977, DSIP's gene, receptor, and role in sleep remain unidentified — and the real sleep-promoting molecule may be a related peptide that hasn't been found yet.

Kovalzon, Vladimir M et al.·Journal of neurochemistry·2006·earlyReview
RPEP-01156Reviewearly2006RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Review
Evidence
early
Sample
Review of animal studies (rabbits, rats, various vertebrate species)
Participants
Review of animal studies (rabbits, rats, various vertebrate species)

What This Study Found

Despite being isolated in 1977, delta sleep-inducing peptide (DSIP) remains poorly understood. Its gene, protein precursor, and receptor have never been identified, and its role as a sleep factor is 'extremely poorly documented.' The authors hypothesize that a DSIP-like peptide — not DSIP itself — may be responsible for the observed biological activity. Key evidence: DSIP structural analogs (but not DSIP itself) promoted slow-wave sleep in rabbits and rats, and a naturally occurring peptide structurally similar to DSIP also promoted slow-wave sleep while its mirror-image isomer suppressed sleep.

Key Numbers

Discovered: 1977 · 9 amino acids · Gene: never isolated · Receptor: never identified · DSIP analogs (not DSIP itself) promoted SWS in rabbits and rats

How They Did This

Mini-review synthesizing histochemical, biochemical, physiological, and sleep research findings on DSIP and related peptides across multiple vertebrate species.

Why This Research Matters

DSIP is one of the most mysterious peptides in neuroscience — discovered nearly 50 years ago but still without an identified gene, receptor, or clear biological function. This review honestly assesses the weak evidence for DSIP as a sleep peptide while proposing that a related, undiscovered peptide may be the actual bioactive molecule. It's a cautionary tale about how initial discoveries can persist in the literature without proper validation.

The Bigger Picture

DSIP occupies a strange corner of peptide science — widely discussed, commercially available as a research chemical, yet lacking the most basic molecular characterization. This review highlights a broader issue in peptide research: early discoveries can take on a life of their own even when the foundational evidence is thin. The hypothesis that a DSIP-like peptide is the real bioactive molecule remains untested nearly two decades after this review was written.

What This Study Doesn't Tell Us

This is a hypothesis-generating review, not a study with original data. The entire DSIP field suffers from a fundamental problem: the gene and receptor remain unidentified, making rigorous mechanistic study impossible. Many of the cited findings are from decades-old studies that have not been replicated with modern methods.

Questions This Raises

  • ?Has modern genomics or proteomics identified the DSIP gene or a DSIP-like peptide in the years since this review?
  • ?Why does DSIP have such a broad spectrum of reported biological activities if its receptor is unknown?
  • ?Should DSIP research be revisited with modern tools like CRISPR screening or high-resolution proteomics to resolve the mystery?

Trust & Context

Key Stat:
Gene and receptor still unknown after 30+ years Despite being isolated in 1977, DSIP's gene has never been cloned and its receptor has never been identified — a unique situation for a named bioactive peptide
Evidence Grade:
This is a mini-review that honestly acknowledges the weakness of the evidence for DSIP as a sleep factor. The authors describe the hypothesis as 'extremely poorly documented and still weak.' The underlying research consists mostly of older animal studies with inconsistent results.
Study Age:
Published in 2006, this review covers research from 1977-2006. The fundamental questions it raises — DSIP's gene, receptor, and true biological role — appear to remain largely unanswered as of the mid-2020s.
Original Title:
Delta sleep-inducing peptide (DSIP): a still unresolved riddle.
Published In:
Journal of neurochemistry, 97(2), 303-9 (2006)
Database ID:
RPEP-01156

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

Summarizes existing research on a topic.

What do these levels mean? →

Frequently Asked Questions

Does DSIP actually help you sleep?

The evidence is surprisingly weak. Despite its name, DSIP has never been convincingly shown to promote sleep on its own. Ironically, modified versions of DSIP promoted slow-wave sleep in animal studies better than DSIP itself. The researchers behind this review suggest the real sleep-promoting molecule may be a related peptide that hasn't been discovered yet.

Is DSIP safe to use as a supplement?

DSIP's safety profile is essentially unknown because its gene, receptor, and mechanism of action have never been identified. Without understanding how a molecule works in the body, its long-term safety cannot be properly assessed. It is not approved by the FDA for any medical use.

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-01156·https://rethinkpeptides.com/research/RPEP-01156

APA

Kovalzon, Vladimir M; Strekalova, Tatyana V. (2006). Delta sleep-inducing peptide (DSIP): a still unresolved riddle.. Journal of neurochemistry, 97(2), 303-9.

MLA

Kovalzon, Vladimir M, et al. "Delta sleep-inducing peptide (DSIP): a still unresolved riddle.." Journal of neurochemistry, 2006.

RethinkPeptides

RethinkPeptides Research Database. "Delta sleep-inducing peptide (DSIP): a still unresolved ridd..." RPEP-01156. Retrieved from https://rethinkpeptides.com/research/kovalzon-2006-delta-sleepinducing-peptide-dsip

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.